PHARMACOCINÉTIQUE AMÉLIORÉE ET CIBLAGE DU RÉCEPTEUR CHOLECYSTOKININ-2 (CCK2R) POUR LE DIAGNOSTIC ET LA THÉRAPIE

• 收藏
• 分享

专利权人:

Medizinische Universität Innsbruck

发明人:

申请号：

EP17174973.2

公开号：

EP3412303A1

申请日:

2017.06.08

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention provides valuable peptidomimetics for therapeutic and diagnostic purposes as well as compositions, methods, uses and kits based on these peptidomimetics. In particular, the peptidomimetics of the present invention are incorporated by CCK2R expressing cells, for instance, cancer cells. This allows, for instance, to selectively destroy cancer cells or to selectively image cancer cells that express CCK2R.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/